Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
loratadine; montelukast · 1 trial · 1 indication
| Name | Type | Description |
|---|---|---|
| loratadine; montelukast | DRUG | - |
Inclusion Criteria: * Aged 15 years or older, of either sex and of any race. * At least a 2-year documented history of SAR with symptoms during the study season. * A positive skin-prick test response to seasonal * Clinically symptomatic at Screening and at the Baseline Visits * General good health....